1. 1. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology--drug disposition, action, and therapy in infants and children. N Engl J Med 2003; 349: 1157–1167.
2. 2. The handling of drugs in off-label use. Notice from the Ministry of Health, Labour and Welfare, Ken No. 4, Iyakushin No. 104, issued on February 1, 1999 (in Japanese).
3. 3. Heimann G. Enteral absorption and bioavailability in children in relation to age. Eur J Clin Pharmacol 1980; 18: 43–50.
4. 4. de Wildt SN, Kearns GL, Leeder JS, van den Anker JN. Cytochrome P450 3A: Ontogeny and drug disposition. Clin Pharmacokinet 1999; 37: 485–505.
5. 5. Maples HD, James LP, Stowe CD. Special pharmacokinetis and pharmacodynamic considerations in children. In: Burton ME, Shaw LM, Schentag JJ, Evans WE, editors. Applied pharmacokinetics & pharmacodynamics, 4th edn. Philadelphia, Lippincott Wiliams & Wilkins, 2004: 213–259.